Betahistine dihydrochloride 16mg;   - search results

betahistine actavis 16mg tablets

actavis group h.f. reykjavikurvegur 78, 220 hafnarfjörður, iceland - betahistine dihydrochloride - tablet - betahistine dihydrochloride 16 mg - other nervous system drugs

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

betahistine 16mg tablets

milpharm ltd - betahistine dihydrochloride - oral tablet - 16mg

Ireland - English - HPRA (Health Products Regulatory Authority)

betahistine dihydrochloride

accord healthcare limited - betahistine dihydrochloride - tablets - 8 milligram - betahistine

New Zealand - English - Medsafe (Medicines Safety Authority)

serc

Ireland - English - HPRA (Health Products Regulatory Authority)

betahistine dihydrochloride 16 mg tablets

azure pharmaceuticals ltd - betahistine dihydrochloride - tablet - betahistine

Ireland - English - HPRA (Health Products Regulatory Authority)

betahistine dihydrochloride 8mg tablets

accord healthcare ireland ltd. - betahistine dihydrochloride - tablet - 8 milligram(s) - antivertigo preparations; betahistine

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

betahistine dihydrochloride 8mg tablets tablets

accord healthcare limited - betahistine (betahistine dihydrochloride) - tablets - 8mg

betahistine dihydrochloride 8mg tablets tablets

accord healthcare limited - betahistine (betahistine dihydrochloride) - tablets - 8mg

Australia - English - Department of Health (Therapeutic Goods Administration)

serc betahistine dihydrochloride 16 mg tablet blister pack

viatris pty ltd - betahistine dihydrochloride, quantity: 16 mg - tablet, uncoated - excipient ingredients: colloidal anhydrous silica; microcrystalline cellulose; mannitol; citric acid monohydrate; purified talc - meniere's syndrome as defined by the following core symptoms: - vertigo (with nausea/vomiting): - hearing loss (hardness of hearing): - tinnitus.

New Zealand - English - Medsafe (Medicines Safety Authority)

vergo 16

viatris limited - betahistine dihydrochloride 16mg; - tablet - 16 mg - active: betahistine dihydrochloride 16mg excipient: citric acid monohydrate colloidal silicon dioxide mannitol microcrystalline cellulose purified talc purified water - m?ni?re's syndrome as defined by the following core symptoms: · vertigo (with nausea/vomiting) · hearing loss (hardness of hearing) · tinnitus